FdaApplication
ANDA 202074
Identifiers
- fda_app_no: ANDA202074
Properties
| Property | Value |
|---|---|
| applicant_name | TEVA PHARMACEUTICALS USA |
| application_type | ANDA |
| approval_date | 2013-03-25 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | FLUOXETINE HYDROCHLORIDE; OLANZAPINE | EQ 25MG BASE;EQ 3MG BASE | CAPSULE;ORAL |
1 product